Reverse transcription-3 ' rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 mRNA as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model
Cn. Okeke et al., Reverse transcription-3 ' rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 mRNA as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model, J INVES DER, 114(1), 2000, pp. 95-100
The presence of viable cells of Candida albicans, in broth or in a reconstr
ucted living skin equivalent, was determined by the detection of amplicons
of partial mRNA sequences of the genes encoding fungal actin (ACT1) and sec
reted aspartyl proteinase 2 (SAP2). The mRNA of both genes were amplified b
y reverse transcription-3' rapid amplification of cDNA ends-nested polymera
se chain reaction. Single bands of ACT1 (315 bp) and SAP2 (162 bp) mRNA wer
e amplified from total RNA extracts of C. albicans grown in yeast carbon ba
se-albumin broth or in living skin equivalent tissue; only the former was a
mplified from Sabouraud broth-grown organisms. Primer pairs targeted for AC
T1 and SAP2 were Candida genus-specific and C. albicans-specific, respectiv
ely. The sensitivity limits of the assay were 100 fg of total RNA or 10 cel
ls of C. albicans, by ethidium bromide staining. When C. albicans-infected
living skin equivalent was exposed to amorolfine, amplicons of ACT1 and SAP
2 mRNA were not detected in total RNA extracts. Non-amplification of the mR
NA correlated with the absence of C. albicans growth in Sabouraud agar cult
ures of living skin equivalent samples. Reverse transcription-3' rapid ampl
ification of cDNA ends-nested polymerase chain reaction of the mRNA encodin
g specific proteins of an organism has potential application in determining
the viability of the organism in tissue, thus monitoring the efficacy of a
n antimicrobial therapy, and in detecting mRNA expressed in very little amo
unts in tissue.